Retinoic acid receptor‐alpha as a prognostic indicator in oral squamous cell carcinoma

Retinoids reverse potentially malignant lesions and inhibit the development of second primary tumors in oral cancer patients by binding to nuclear retinoid receptors. Alterations in the expression of retinoid receptor‐alpha are implicated in tumor progression. Herein, we hypothesized that increased expression of RARα protein in oral squamous cell carcinoma (SCC) is associated with a poor clinical outcome and thus may serve as a prognostic factor. Retrospective immunohistochemical analysis of RARα protein expression was carried out in paraffin‐embedded tissue sections from 115 patients with completely resected oral SCCs for whom clinical follow‐up data were available. Increased expression of RARα protein was observed in 67/115 (58%) oral SCCs (weakly positive in 38 patients and strongly positive in 29 patients). Kaplan‐Meier analysis showed that patients with RARα positivity had significantly shorter disease‐free survival time (median time 40 months vs. 86 months, p = 0.0229). Furthermore, disease‐free survival time of the 29 patients with strongly positive RARα was significantly worse than for the 86 patients with weak or undetectable levels of RARα (p = 0.0328). Strong RARα expression in oral SCCs was associated with a significantly worse disease‐free survival, suggesting that RARα may serve as a prognostic indicator of poor clinical outcome. Further studies are warranted to determine its utility in identifying the subset of patients who would benefit from use of retinoids as adjuvant in chemotherapy or chemopreventive approaches. © 2002 Wiley‐Liss, Inc.

[1]  R. Lotan,et al.  Differential effects of chromosome 3p deletion on the expression of the putative tumor suppressor RARβ and on retinoid resistance in human squamous carcinoma cells , 2001, Oncogene.

[2]  T. Enver,et al.  Lineage restriction of the RARα gene expression in myeloid differentiation , 2001 .

[3]  D. Alberts,et al.  Progressive decreases in nuclear retinoid receptors during skin squamous carcinogenesis. , 2001, Cancer research.

[4]  Takemi Tanaka,et al.  Involvement of all-trans-retinoic acid in the breakdown of retinoic acid receptors α and γ through proteasomes in mcf-7 human breast cancer cells , 2001 .

[5]  S. Groshen,et al.  Retinoic acid receptor-α messenger RNA expression is increased and retinoic acid receptor-γ expression is decreased in Barrett's intestinal metaplasia, dysplasia, adenocarcinoma sequence , 2001 .

[6]  P. Chambon,et al.  Positive and negative regulation of granulopoiesis by endogenous RARalpha. , 2001, Blood.

[7]  T. Grunt,et al.  Activation of retinoic acid receptor alpha is sufficient for full induction of retinoid responses in SK-BR-3 and T47D human breast cancer cells. , 2000, Cancer research.

[8]  T. Salo,et al.  Prognostic factors in tongue cancer – relative importance of demographic, clinical and histopathological factors , 2000, British Journal of Cancer.

[9]  S. Lippman,et al.  Retinoic acid receptor-beta as a prognostic indicator in stage I non-small-cell lung cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  M. Koken,et al.  Retinoic Acid Induces Proteasome-Dependent Degradation of Retinoic Acid Receptor α (RARα) and Oncogenic RARα Fusion Proteins , 1999 .

[11]  S. Lippman,et al.  Loss of retinoic acid receptor-beta expression is an early event during esophageal carcinogenesis. , 1999, The American journal of pathology.

[12]  C. Haglund,et al.  Concentration of free hCGβ subunit in serum as a prognostic marker for squamous‐cell carcinoma of the oral cavity and oropharynx , 1999 .

[13]  W. Hong,et al.  Overexpression of retinoic acid receptor beta in head and neck squamous cell carcinoma cells increases their sensitivity to retinoid-induced suppression of squamous differentiation by retinoids. , 1999, Cancer research.

[14]  H. Harn,et al.  Expression of nuclear retinoid receptors in normal, premalignant and malignant gastric tissues determined by in situ hybridization , 1999, British Journal of Cancer.

[15]  S. Fujieda,et al.  IL-10 expression is associated with the expression of platelet-derived endothelial cell growth factor and prognosis in oral and oropharyngeal carcinoma. , 1999, Cancer letters.

[16]  P. Rochaix,et al.  Reduced expression of retinoic acid receptor beta protein (RARβ) in human papillary thyroid carcinoma: immunohistochemical and Western blot study , 1998, Histopathology.

[17]  A. Patchefsky,et al.  Cellular distribution of retinoic acid receptor-alpha protein in serous adenocarcinomas of ovarian, tubal, and peritoneal origin: comparison with estrogen receptor status. , 1998, The American journal of pathology.

[18]  R. Lotan.  Retinoids and their receptors in modulation of differentiation, development, and prevention of head and neck cancers. , 1996, Anticancer research.

[19]  P. Chambon.  A decade of molecular biology of retinoic acid receptors , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[20]  B. van der Burg,et al.  Immunohistochemical analysis of retinoic acid receptor-alpha in human breast tumors: retinoic acid receptor-alpha expression correlates with proliferative activity. , 1996, American Journal of Pathology.

[21]  John Calvin Reed,et al.  Retinoic acid receptor beta mediates the growth-inhibitory effect of retinoic acid by promoting apoptosis in human breast cancer cells , 1996, Molecular and cellular biology.

[22]  R. Lotan,et al.  Differential expression of nuclear retinoid receptors in normal, premalignant, and malignant head and neck tissues. , 1994, Cancer research.

[23]  M. Pfahl.  Vertebrate receptors: molecular biology, dimerization and response elements. , 1994, Seminars in cell biology.

[24]  P. Chambon,et al.  RARs and RXRs: evidence for two autonomous transactivation functions (AF‐1 and AF‐2) and heterodimerization in vivo. , 1993, The EMBO journal.

[25]  W. Zheng,et al.  Serum micronutrients and the subsequent risk of oral and pharyngeal cancer. , 1993, Cancer research.

[26]  P. Chambon,et al.  Promoter context- and response element-dependent specificity of the transcriptional activation and modulating functions of retinoic acid receptors , 1992, Cell.

[27]  P. Chambon,et al.  Immunodetection of multiple species of retinoic acid receptor α : evidence for phosphorylation , 1992 .

[28]  P. Chambon,et al.  RAR-beta 4, a retinoic acid receptor isoform is generated from RAR-beta 2 by alternative splicing and usage of a CUG initiator codon. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[29]  P. Chambon,et al.  Mouse retinoic acid receptor alpha 2 isoform is transcribed from a promoter that contains a retinoic acid response element. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[30]  D. Sugarbaker,et al.  High frequency of retinoic acid receptor beta abnormalities in human lung cancer. , 1991, Oncogene.

[31]  P. Chambon,et al.  Multiple isoforms of the mouse retinoic acid receptor alpha are generated by alternative splicing and differential induction by retinoic acid. , 1991, The EMBO journal.

[32]  Rajanna,et al.  A population-based case-control investigation on cancers of the oral cavity in Bangalore, India. , 1990, British Journal of Cancer.

[33]  S. Shapshay,et al.  Patterns of relapse in locally advanced head and neck cancer patients who achieved complete remission after combined modality therapy , 1985, Cancer.

[34]  N. Wald,et al.  LOW SERUM-VITAMIN-A AND SUBSEQUENT RISK OF CANCER Preliminary Results of a Prospective Study , 1980, The Lancet.

[35]  S. Wolbach,et al.  TISSUE CHANGES FOLLOWING DEPRIVATION OF FAT-SOLUBLE A VITAMIN , 1925, The Journal of experimental medicine.

[36]  G. Sakellaropoulos,et al.  Immunohistochemical detection of retinoic acid receptorα in prostate carcinoma: Correlation with proliferative activity and tumor grade , 2004, International Urology and Nephrology.

[37]  R. Ralhan,et al.  Expression of RARα and RARβ in human oral potentially malignant and neoplastic lesions , 2001 .

[38]  J. Ferlay,et al.  Globocan 2000 : cancer incidence, mortality and prevalence worldwide , 2001 .

[39]  X. C. Xu,et al.  Detection of altered retinoic acid receptor expression in tissue sections using in situ hybridization. , 2001, Histology and histopathology.

[40]  H. Quon,et al.  Potential molecular prognostic markers in head and neck squamous cell carcinomas. , 2001, Head & neck.

[41]  S. Groshen,et al.  Retinoic acid receptor-alpha messenger RNA expression is increased and retinoic acid receptor-gamma expression is decreased in Barrett's intestinal metaplasia, dysplasia, adenocarcinoma sequence. , 2001, Surgery.

[42]  L. D. De Luca,et al.  Involvement of all-trans-retinoic acid in the breakdown of retinoic acid receptors alpha and gamma through proteasomes in MCF-7 human breast cancer cells. , 2001, Biochemical pharmacology.

[43]  C. Haglund,et al.  Concentration of free hCGbeta subunit in serum as a prognostic marker for squamous-cell carcinoma of the oral cavity and oropharynx. , 1999, International journal of cancer.

[44]  P. Chambon,et al.  Immunodetection of multiple species of retinoic acid receptor alpha: evidence for phosphorylation. , 1992, Experimental cell research.